Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Neuropharmacology. 2017 Jan 13;116:371–386. doi: 10.1016/j.neuropharm.2017.01.010

Table 3.

5XFAD behavior: 9 month – pump study.

Behavior age (mon.) wildtype – vehicle wildtype - xamoterol 5XFAD - vehicle 5XFAD – xamoterol Statistics
pre-dose Open Field (distance moved, cm) 3.1 6686.8 ± 279.1 6502.9 ± 176.4 6208.2 ± 719.8 6886.7 ± 374.3 one-way ANOVA
NS

pre-dose Y-Maze (% alternation) 3.2 54.4 ± 2.7 53.8 ± 2.3 *57.2 ± 2.7 *57.8 ± 2.7 one sample t-tests versus chance (50%); * p < .05

Activity Chamber (distance moved, cm) 8.0 4418.7 ± 564.8 5192.5 ± 385.9 5053.3 ± 571.0 4487.6 ± 300.7 one-way ANOVA
NS

Y-Maze (% alternation) 8.1 53.6 ± 2.3 *58.8 ± 3.0 *57.8 ± 2.7 *55.8 ± 2.2 one sample t-tests versus chance (50%); * p < .05

NOR (discrimination ratio) 8.4 0.239 ± 0.052 0.158 ± 0.043 0.159 ± 0.066 0.305 ± 0.066 one-way ANOVA
NS

Morris Water Maze (escape latency; sec) 8.8 two-way ANOVA
 day 1 52.0 ± 3.6 36.7 ± 4.0 50.1 ± 3.3 51.6 ± 3.3 DAY: F(3,30) = 44.84
***p < 0.001
 day 2 29.9 ± 4.0 28.4 ± 6.8 40.3 ± 4.0 33.4 ± 4.9 GROUP: F(3,30) = 2.612; p = .060; TREND
 day 3 36.1 ± 4.1 19.9 ± 5.6 29.0 ± 4.0 20.7 ± 3.4 INTERACTION: F(9,30) = 1.982
p = .051; TREND
 day 4 29.9 ± 4.5 16.6 ± 4.1 19.4 ± 2.8 17.0 ± 2.2
MWM - probe trial (target quadrant ratio) 2.60 ± 0.74 *5.00 ± 1.46 *6.07 ± 1.30 *4.24 ± 0.94 one sample t-tests
* ratio > 1.0; * p < .05

Elevated Plus Maze (% time open arms) 9.1 9.9 ± 2.6 7.5 ± 1.4 18.2 ± 5.2 11.1 ± 2.9 one-way ANOVA
NS

Fear Conditioning one-way ANOVA
Acquisition (% freezing – trace) 9.3 34.7 ± 7.6 57.5 ± 7.9 37.1 ± 7.9 42.5 ± 5.9 NS
Cued Recall (% freezing – trace) 9.3 30.3 ± 7.2 20.2 ± 5.8 29.4 ± 7.3 33.6 ± 4.3 NS
Contextual Recall (% freezing min 2–5) 9.3 27.1 ± 7.5 32.1 ± 9.1 19.8 ± 4.7 16.8 ± 3.1 NS